Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2014

01-11-2014 | Original Article

Prevalence of Uninvestigated Dyspepsia and Gastroesophageal Reflux Disease in Korea: A Population-Based Study Using the Rome III Criteria

Authors: Byung-Hoon Min, Kyu Chan Huh, Hye-Kyung Jung, Young Hoon Yoon, Kee Don Choi, Kyung Ho Song, Bora Keum, Jung Won Kim, Functional Dyspepsia Study Group of Korean Society of Neurogastroenterology and Motility

Published in: Digestive Diseases and Sciences | Issue 11/2014

Login to get access

Abstract

Background/Aims

There have been few population-based studies on the prevalences of gastroesophageal reflux disease (GERD) and dyspepsia using Rome III criteria in Asian countries.

Methods

A population-based, cross-sectional study was conducted by telephone interviews of 5,000 Koreans between the ages of 20–69 years. Gastrointestinal symptoms were assessed by a translated Korean version of Rome III criteria. Uninvestigated dyspepsia (UID) was defined by symptom criteria of Rome III. GERD was defined by troublesome heartburn and/or acid regurgitation occurring at least once a week. The EQ5D assessment tool was used for the evaluation of quality of life.

Results

The prevalences of UID, postprandial distress syndrome (PDS), and epigastric pain syndrome (EPS) were 7.7, 5.6, and 4.2 %, respectively. Overlap between PDS and EPS was found in 27.1 % (104/384) of subjects with UID. There were no significant differences in demographic variables between patients with PDS and EPS. The prevalence of GERD was 7.1 %. Overlap between GERD and UID was found in 50.0 % of GERD patients. The EQ5D index of patients without either UID or GERD was 0.92 ± 0.07, and those of patients with only UID, with only GERD, and with both UID and GERD were 0.88 ± 0.09, 0.88 ± 0.11, and 0.84 ± 0.15, respectively.

Conclusions

GERD and UID based on Rome III criteria were prevalent and significantly affected the quality of life in Korea. In Korean patients with UID, there was considerable overlap and there were no significant differences in demographic variables between PDS and EPS.
Literature
1.
go back to reference Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–1822.PubMedCrossRef Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–1822.PubMedCrossRef
2.
go back to reference Lu CL, Lang HC, Chang FY, et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol. 2005;40:402–411.PubMedCrossRef Lu CL, Lang HC, Chang FY, et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol. 2005;40:402–411.PubMedCrossRef
3.
go back to reference Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef
4.
go back to reference Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920; quiz 1943. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920; quiz 1943.
5.
6.
go back to reference Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.PubMedCrossRef Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.PubMedCrossRef
7.
go back to reference Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201.PubMedCrossRef Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201.PubMedCrossRef
8.
go back to reference Yang SY, Lee OY, Bak YT, et al. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci. 2008;53:188–193.PubMedCrossRef Yang SY, Lee OY, Bak YT, et al. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci. 2008;53:188–193.PubMedCrossRef
9.
go back to reference Lim SL, Goh WT, Lee JM, Ng TP, Ho KY. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol. 2005;20:995–1001.PubMedCrossRef Lim SL, Goh WT, Lee JM, Ng TP, Ho KY. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol. 2005;20:995–1001.PubMedCrossRef
10.
go back to reference Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137:94–100.PubMedCrossRef Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137:94–100.PubMedCrossRef
11.
go back to reference Zagari RM, Law GR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010;138:1302–1311.PubMedCrossRef Zagari RM, Law GR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010;138:1302–1311.PubMedCrossRef
12.
go back to reference Mak AD, Wu JC, Chan Y, Chan FK, Sung JJ, Lee S. Dyspepsia is strongly associated with major depression and generalised anxiety disorder—a community study. Aliment Pharmacol Ther. 2012;36:800–810.PubMedCrossRef Mak AD, Wu JC, Chan Y, Chan FK, Sung JJ, Lee S. Dyspepsia is strongly associated with major depression and generalised anxiety disorder—a community study. Aliment Pharmacol Ther. 2012;36:800–810.PubMedCrossRef
13.
go back to reference Wang A, Liao X, Xiong L, et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol. 2008;8:43.PubMedCrossRefPubMedCentral Wang A, Liao X, Xiong L, et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol. 2008;8:43.PubMedCrossRefPubMedCentral
14.
go back to reference Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007;102:1983–1989.PubMedCrossRef Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007;102:1983–1989.PubMedCrossRef
15.
go back to reference Vakil N, Halling K, Ohlsson L, Wernersson B. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol. 2013;108:767–774.PubMedCrossRef Vakil N, Halling K, Ohlsson L, Wernersson B. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol. 2013;108:767–774.PubMedCrossRef
16.
go back to reference Hsu YC, Liou JM, Yang TH, et al. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? J Gastroenterol. 2011;46:183–190.PubMedCrossRef Hsu YC, Liou JM, Yang TH, et al. Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups? J Gastroenterol. 2011;46:183–190.PubMedCrossRef
17.
go back to reference Ohara S, Kawano T, Kusano M, Kouzu T. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan. J Gastroenterol. 2011;46:603–611.PubMedCrossRef Ohara S, Kawano T, Kusano M, Kouzu T. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan. J Gastroenterol. 2011;46:603–611.PubMedCrossRef
18.
go back to reference Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association National Survey. Circulation. 2013;127:1254–1263, e1251–e1229. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association National Survey. Circulation. 2013;127:1254–1263, e1251–e1229.
19.
go back to reference Myung SK, Seo HG, Cheong YS, Park S, Lee WB, Fong GT. Association of sociodemographic factors, smoking-related beliefs, and smoking restrictions with intention to quit smoking in Korean adults: findings from the ITC Korea Survey. J Epidemiol. 2012;22:21–27.PubMedCrossRefPubMedCentral Myung SK, Seo HG, Cheong YS, Park S, Lee WB, Fong GT. Association of sociodemographic factors, smoking-related beliefs, and smoking restrictions with intention to quit smoking in Korean adults: findings from the ITC Korea Survey. J Epidemiol. 2012;22:21–27.PubMedCrossRefPubMedCentral
20.
go back to reference Song KH, Jung HK, Min BH, et al. Development and validation of the Korean Rome III Questionnaire for diagnosis of functional gastrointestinal disorders. J Neurogastroenterol Motil. 2013;19:509–515.PubMedCrossRefPubMedCentral Song KH, Jung HK, Min BH, et al. Development and validation of the Korean Rome III Questionnaire for diagnosis of functional gastrointestinal disorders. J Neurogastroenterol Motil. 2013;19:509–515.PubMedCrossRefPubMedCentral
21.
go back to reference Kang EJ, Park HJ, Kim NY. A valuation of health status using EQ-5D. Korean J Health Econ Policy. 2006;12:19–43. Kang EJ, Park HJ, Kim NY. A valuation of health status using EQ-5D. Korean J Health Econ Policy. 2006;12:19–43.
22.
go back to reference Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.PubMedCrossRef Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.PubMedCrossRef
24.
go back to reference Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther. 2002;16:2081–2088.PubMedCrossRef Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther. 2002;16:2081–2088.PubMedCrossRef
25.
go back to reference Hong SJ, Sung IK, Kim JG, et al. Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori-infected patients with functional dyspepsia. Gut Liver. 2011;5:468–471.PubMedCrossRefPubMedCentral Hong SJ, Sung IK, Kim JG, et al. Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori-infected patients with functional dyspepsia. Gut Liver. 2011;5:468–471.PubMedCrossRefPubMedCentral
26.
go back to reference Manabe N, Haruma K, Hata J, et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol. 2010;45:567–572.PubMedCrossRef Manabe N, Haruma K, Hata J, et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol. 2010;45:567–572.PubMedCrossRef
27.
go back to reference Choung RS, Locke GR, III, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012;24:229–234, e106. Choung RS, Locke GR, III, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012;24:229–234, e106.
28.
go back to reference Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut. 2005;54:1370–1376.PubMedCrossRefPubMedCentral Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut. 2005;54:1370–1376.PubMedCrossRefPubMedCentral
29.
go back to reference Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the bond and opera studies). Aliment Pharmacol Ther. 1998;12:1055–1065.PubMedCrossRef Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the bond and opera studies). Aliment Pharmacol Ther. 1998;12:1055–1065.PubMedCrossRef
30.
go back to reference Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004;99:2210–2216.PubMedCrossRef Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004;99:2210–2216.PubMedCrossRef
31.
go back to reference Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International gastroenterology surveillance study. Am J Gastroenterol. 1999;94:2845–2854.PubMedCrossRef Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International gastroenterology surveillance study. Am J Gastroenterol. 1999;94:2845–2854.PubMedCrossRef
32.
go back to reference Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol. 2006;41:149–154.PubMedCrossRef Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol. 2006;41:149–154.PubMedCrossRef
33.
go back to reference Carey RN, Reid A, Driscoll TR, Glass DC, Benke G, Fritschi L. An advance letter did not increase the response rates in a telephone survey: a randomized trial. J Clin Epidemiol. 2013;66:1417–1421. Carey RN, Reid A, Driscoll TR, Glass DC, Benke G, Fritschi L. An advance letter did not increase the response rates in a telephone survey: a randomized trial. J Clin Epidemiol. 2013;66:1417–1421.
34.
go back to reference Koepsell TD, McGuire V, Longstreth WT Jr, Nelson LM, van Belle G. Randomized trial of leaving messages on telephone answering machines for control recruitment in an epidemiologic study. Am J Epidemiol. 1996;144:704–706.PubMedCrossRef Koepsell TD, McGuire V, Longstreth WT Jr, Nelson LM, van Belle G. Randomized trial of leaving messages on telephone answering machines for control recruitment in an epidemiologic study. Am J Epidemiol. 1996;144:704–706.PubMedCrossRef
35.
go back to reference Majowicz SE, Edge VL, Flint J, et al. An introductory letter in advance of a telephone survey may increase response rate. Can Commun Dis Rep. 2004;30:121–123.PubMed Majowicz SE, Edge VL, Flint J, et al. An introductory letter in advance of a telephone survey may increase response rate. Can Commun Dis Rep. 2004;30:121–123.PubMed
Metadata
Title
Prevalence of Uninvestigated Dyspepsia and Gastroesophageal Reflux Disease in Korea: A Population-Based Study Using the Rome III Criteria
Authors
Byung-Hoon Min
Kyu Chan Huh
Hye-Kyung Jung
Young Hoon Yoon
Kee Don Choi
Kyung Ho Song
Bora Keum
Jung Won Kim
Functional Dyspepsia Study Group of Korean Society of Neurogastroenterology and Motility
Publication date
01-11-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3243-y

Other articles of this Issue 11/2014

Digestive Diseases and Sciences 11/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine